Market Prospects For New Cholesterol Lowering Agents Nexletol And Nexlizet Ultimately, sales of Nexletol and Nexlizet will be driven by insurer uptake, which in turn will depend on the net price after rebates, as well as an assessment of relative cost- and clinical effectiveness.